Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.Amarantus is active in…
Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.
Amarantus is active in exploring a number of strategic options for Amarantus Diagnostics, including a potential spin off, to derive the full value of its premier neurodiagnostics business.
Team (1)
Sectors Amarantus serves:
Life Sciences
Join Axial's Private M&A Platform
Amarantus connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
